ArticleOncology letters2021

Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin-resistant human epidermal growth factor receptor 2-positive breast cancer.

Junjun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.